Abstract
A screening assay for the detection of antibodies to hepatitis C virus (HCV); ORTHOTM HCV ELISA Test System, Second Generation, was compared with the currently licensed c100-3 based test (ORTHOTM HCV ELISA Test System). The second generation ELISA differs from the c100-3 based assay in that it detects circulating antibodies to both structural (nucleocapsid) and non-structural (NS3/NS4) HCV proteins. Specimens tested consisted of a cohort of 35 patients diagnosed with non-A, non-B hepatitis (NANBH) and 3971 presumably healthy volunteer blood donors. Second generation ELISA demonstrated significantly greater clinical sensitivity in patients with acute phase NANBH (80% vs. 60%) as well as chronic disease (88% vs. 72%). Additional specimens reactive only in second generation ELISA, demonstrated reactivity to HCV antigens c33c and/or c22-3 in supplemental testing by the Chiron HCV RIBA tm Assay System. The second generation ELISA also detected additional RIBA reactive volunteer blood donors (0.18% of the population tested) that were nonreactive in first generation ELISA. This data indicated that second generation ELISA would detect approximately 2 additional antiHCV reactive donors per 1,000 screened. Specificities obtained with this low risk population were 99.6% for first generation and 99.7% for second generation ELISA.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agius, C., Tupper, B., Garcia, G., Botsko, E., Malka, E., Le, A.V., Krauledat, P., DiNello, R., Quan, S., Chien, D., Polito, A., and Nelles, M., 1989, ORTHO HCV Antibody ELISA Test System for the detection of antibodies to hepatitis C (non-A, non-B hepatitis) virus, (Abstr.), 1st International Meeting on Hepatitis C Virus, Rome, Italy.
Alter, H.J., Purcell, R.H., Shih, J.W., Melpolder, J.C., Houghton, M., Choo, Q.-L., and Kuo, G., 1989, Detection of antibodies to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis, N. Engl. J. Med. 321:1494–1500.
Bradley, D.W., Maynard, J.E., Popper, H., Cook, E.H., Ebert, J.W., McCaustland, K.A., Schable, C.A., and Fields, H.A., 1983, Post transfusion non-A, non-B hepatitis: physiochemical properties of two distinct agents J. Infect. Dis. 148:254–265.
Choo, Q.-L., Kuo, G., Deiner, A.J., Overby, L.R., Bradley, D.W., and Houghton, M., 1989, Isolation of cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome, Science 244:359–362.
Contreras, M., and Barbara, J.A.J., 1989, Screening for hepatitis C antibody,Lancet ii:796–797.
Hopf, U., Moller, B., Kuther, D., Stemerowicz, R., Lobeck, H., Ludtke-Handjery, A., Walter, E., Blum, H., Rogegendorf, M., and Deinhardt, F., 1990, Long-term follow-up of post-transfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV), J. Hepatol. 10 (1):69–76.
Kuhnl, P., Seidl, S., Stangel, W., Beyer, J., Sibrowski, W., and Flik, J., 1989, Antibody to hepatitis C in German blood donors, Lancet ii:324–325.
Kuo, G., Choo, Q.-L., Alter, H.J., Gitnick, G.L., Redeker, A.G., Purcell, R.H., Miyamura, T., Dienstag, J.L., Alter, M.J., Stevens, C.E., Tegtmeier, G.E., Bonino, F., Colombo, M., Lee, W.-S., Kuo, C., Berger, K., Shuter, J.R., Overby, L.R., Bradley, D.W., and Houghton, M., 1989, An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis, Science 244:362–364.
Sircha, G., Bellobuono, A., Giovanetti, A., and Marconi, M., 1989, Antibodies to hepatitis C virus in Italian blood donors,Lancet ii:797.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lee, S. et al. (1992). Improved Detection of Antibodies to Hepatitis C Virus Using a Second Generation Elisa. In: Block, T.M., Jungkind, D., Crowell, R.L., Denison, M., Walsh, L.R. (eds) Innovations in Antiviral Development and the Detection of Virus Infections. Advances in Experimental Medicine and Biology, vol 312. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3462-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3462-4_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6533-4
Online ISBN: 978-1-4615-3462-4
eBook Packages: Springer Book Archive